The HDDC Pilot-Feasibility (P/F) Grant Program is a centerpiece of HDDC activities with an important impact on future advances in digestive disease research. The P/F Program provides funding ($25 K for 1 year) that primarily targets young investigators in the process of establishing their independent research careers, but also allows established investigators to initiate innovative and promising pilot projects that could lead to substantial funding for new lines of research relevant to digestive diseases.
The Specific Aims of the HDDC P/F Program are: 1. To support and encourage young and mentored investigators in digestive disease-related research who have not previously held independent awards (Type I Awards). 2. To entice accomplished investigators from other fields who are not currently focused on digestive diseases to apply new concepts and technical approaches to the digestive tract (Type II awards). 3. To enable established investigators already working in digestive disease-related research to initiate a substantial, innovative change in the direction of their research (Type III awards). The HDDC selects these projects through a rigorous multi-step process modeled on NIH study sections. Proposals are scored on the basis of innovation, scientific merit and the potential for future independent funding in digestive disease research. The success rate of PF awardees in obtaining subsequent grant support has been outstanding. Since 2006 45 investigators have been supported by HDDC P/F grants including 4 current grantees. Of the 41 previous PF awardees, 39 (95 %) subsequently won independent grant funding and all previous grantees but one are still engaged in digestive disease-related research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK034854-31
Application #
8971195
Study Section
Special Emphasis Panel ()
Project Start
Project End
Budget Start
2015-12-01
Budget End
2016-11-30
Support Year
31
Fiscal Year
2016
Total Cost
$191,725
Indirect Cost
$77,000
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Gornati, Laura; Zanoni, Ivan; Granucci, Francesca (2018) Dendritic Cells in the Cross Hair for the Generation of Tailored Vaccines. Front Immunol 9:1484
Blumberg, Richard S; Lillicrap, David; IgG Fc Immune Tolerance Group (2018) Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia Blood 131:2205-2214
Yao, Lina; Seaton, Sarah Craven; Ndousse-Fetter, Sula et al. (2018) A selective gut bacterial bile salt hydrolase alters host metabolism. Elife 7:
Haghighi, Alireza; Krier, Joel B; Toth-Petroczy, Agnes et al. (2018) An integrated clinical program and crowdsourcing strategy for genomic sequencing and Mendelian disease gene discovery. NPJ Genom Med 3:21
Lee, Christine K; Mitchell, Paul D; Raza, Roshan et al. (2018) Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience. J Pediatr 198:84-89.e2
Santus, William; Mingozzi, Francesca; Vai, Marina et al. (2018) Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses. J Vis Exp :
Stein, Richard R; Tanoue, Takeshi; Szabady, Rose L et al. (2018) Computer-guided design of optimal microbial consortia for immune system modulation. Elife 7:
Chen, Peng; Tao, Liang; Wang, Tianyu et al. (2018) Structural basis for recognition of frizzled proteins by Clostridium difficile toxin B. Science 360:664-669
Shaw, Kelly A; Cutler, David J; Okou, David et al. (2018) Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort. Genes Immun :
Lyons, Jesse; Ghazi, Phaedra C; Starchenko, Alina et al. (2018) The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profile. PLoS Biol 16:e2002417

Showing the most recent 10 out of 869 publications